Narmada Gelatines Ltd Valuation Shifts Signal Strong Investment Appeal

Valuation Metrics Reflect Renewed Investor Confidence

Recent data reveals that Narmada Gelatines’ P/E ratio currently stands at 8.79, a significant discount compared to its historical average of approximately 9.91 and far below many of its industry peers. For context, Titan Biotech and Sanstar trade at P/E ratios of 68.8 and 94.16 respectively, underscoring Narmada’s relative valuation appeal. The company’s price-to-book value has also improved to 1.92, reinforcing the notion that the stock is undervalued relative to its net asset base.

Enterprise value multiples further support this narrative. The EV to EBITDA ratio is 7.19, closely aligned with the peer average of 7.19 but substantially lower than the likes of Titan Biotech (56.07) and Sanstar (96.29). This suggests that Narmada Gelatines is trading at a more reasonable enterprise valuation relative to its earnings before interest, tax, depreciation and amortisation.

Strong Operational Metrics Complement Valuation

Beyond valuation, Narmada Gelatines boasts robust operational performance. The company’s return on capital employed (ROCE) is an impressive 20.86%, while return on equity (ROE) stands at 19.40%. These figures indicate efficient capital utilisation and strong profitability, which justify the market’s renewed interest and the upgraded rating. Additionally, the dividend yield of 2.52% adds an income component attractive to yield-conscious investors.

Its PEG ratio of 0.23 further highlights the stock’s undervaluation relative to its earnings growth potential, a stark contrast to peers like Titan Biotech with a PEG of 3.29. This low PEG ratio suggests that the market has yet to fully price in the company’s growth prospects, offering a compelling entry point.

Comparative Analysis Highlights Narmada’s Undervalued Status

When compared with its peer group within the Specialty Chemicals sector, Narmada Gelatines stands out for its very attractive valuation grade. While companies such as Stallion India and Amines & Plastics are classified as expensive with P/E ratios of 37.39 and 31.13 respectively, Narmada’s valuation remains conservative. Even Gulshan Polyols and TGV Sraac, which are also rated very attractive, trade at higher P/E multiples of 28.08 and 9.36 respectively, reinforcing Narmada’s relative bargain status.

Moreover, the company’s EV to capital employed ratio of 1.84 and EV to sales ratio of 1.24 are indicative of efficient capital deployment and revenue generation at a reasonable valuation. These metrics, combined with a micro-cap market capitalisation, suggest that Narmada Gelatines offers significant upside potential as it gains greater market recognition.

Price Movement and Market Returns

Despite a modest day decline of 1.86% to close at ₹396.80, the stock has demonstrated strong returns over multiple time horizons. Year-to-date, Narmada Gelatines has delivered a 14.91% gain, outperforming the Sensex which is down 11.71% over the same period. Over one year, the stock’s return of 23.19% dwarfs the Sensex’s negative 8.84%, while its five-year return of 126.03% more than doubles the benchmark’s 54.39%.

These returns underscore the company’s resilience and growth trajectory, particularly impressive given its micro-cap status and the broader market volatility. The 52-week trading range of ₹317.05 to ₹440.00 further illustrates the stock’s price volatility, yet the current price remains closer to the lower end, enhancing its attractiveness for value investors.

Outlook and Investment Implications

The upgrade in Mojo Grade from Buy to Strong Buy on 15 May 2026 reflects a comprehensive reassessment of Narmada Gelatines’ fundamentals and valuation. With a Mojo Score of 81.0, the company is positioned favourably within the Specialty Chemicals sector, supported by strong financial metrics and a valuation that is compelling relative to peers and historical averages.

Investors seeking exposure to the specialty chemicals space with a focus on undervalued, high-quality micro-cap stocks may find Narmada Gelatines an attractive proposition. The combination of solid returns, robust profitability ratios, and a very attractive valuation grade suggests that the stock is poised for further appreciation as market participants increasingly recognise its potential.

Risks and Considerations

While the valuation metrics and operational performance are encouraging, investors should remain mindful of the inherent risks associated with micro-cap stocks, including liquidity constraints and higher volatility. The recent one-week decline of 5.77% compared to the Sensex’s 2.70% drop highlights short-term price sensitivity. Additionally, the company’s exposure to the specialty chemicals sector means it is subject to raw material price fluctuations and regulatory changes that could impact margins.

Nonetheless, the company’s strong return ratios and low PEG ratio provide a cushion against downside risks, supporting the view that the current valuation presents a favourable entry point for long-term investors.

Conclusion

Narmada Gelatines Ltd’s transition from an attractive to a very attractive valuation grade, coupled with an upgrade to a Strong Buy rating, marks a significant milestone for this micro-cap specialty chemicals company. Its compelling P/E and P/BV ratios, robust profitability metrics, and superior returns relative to the Sensex position it as a noteworthy investment opportunity. While short-term volatility remains a factor, the stock’s fundamentals and valuation profile suggest it is well placed for sustained growth and market outperformance.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →